Limit this search to....

Preventing Drug Abuse: What Do We Know?
Contributor(s): National Research Council (Author), Division of Behavioral and Social Scienc (Author), Commission on Behavioral and Social Scie (Author)
ISBN: 0309046270     ISBN-13: 9780309046275
Publisher: National Academies Press
OUR PRICE:   $42.75  
Product Type: Hardcover - Other Formats
Published: February 1993
Qty:
Temporarily out of stock - Will ship within 2 to 5 weeks
Annotation: This new book provides a comprehensive overview of what we know about drug prevention and its effectiveness, including results of a wide range of antidrug efforts; a profile of the drug problem; an examination of promising prevention techniques from other areas of health and human services; and more. Index. Approx.
Additional Information
BISAC Categories:
- Psychology
Dewey: 362.291
LCCN: 93007333
Physical Information: 0.5" H x 6" W x 8.9" (0.60 lbs) 176 pages
 
Descriptions, Reviews, Etc.
Publisher Description:

As the nation's drug crisis has deepened, public and private agencies have invested huge sums of money in prevention efforts. Are the resulting programs effective? What do we need to know to make them more effective? This book provides a comprehensive overview on what we know about drug abuse prevention and its effectiveness, including:

  • Results of a wide range of antidrug efforts.
  • The role and effectiveness of mass media in preventing drug use.
  • A profile of the drug problem, including a look at drug use by different population groups.
  • A review of three major schools of prevention theory--risk factor reduction, developmental change, and social influence.
  • An examination of promising prevention techniques from other areas of health and human services.

This volume offers provocative findings on the connection between low self-esteem and drug use, the role of schools, the reality of changing drug use in the population, and more.

Preventing Drug Abuse will be indispensable to anyone involved in the search for solutions, including policymakers, anti-drug program developers and administrators, and researchers.